Healthcare
Oriza Seed leads $25m Series A for Shanghai biotech firm
Oriza Seed Venture Capital, an early-stage and growth-stage investment unit under China’s Oriza Holdings, has led a $25 million Series A round for EpimAb Biotherapeutics, a Shanghai-based biopharmaceutical firm.
Korea healthcare: Quickening pulse
Korea’s government is playing a long game by propping up the local health tech start-up ecosystem. VCs that share this vision are identifying the obstacles and planning for growth
AGIC acquires European medical supplier, targets China growth
AGIC Capital has acquired 100% of Slovenia-based medical equipment supplier Fotona as part of a plan to expand operations in Asia with an emphasis on China. The deal will facilitate an exit for US private equity firm The Gores Group.
VCs commit $65m to China vaccine developer CanSino Biologics
SDIC Fund Management, a GP under China’s State Development & Investment Corporation, has led a $65 million round of funding for CanSino Biologics, a China-based vaccine developer.
Antony Leung's New Frontier backs Shenzhen medical group
New Frontier, a private equity firm co-founded by Antony Leung (pictured), formerly Hong Kong's financial secretary, has invested in Best Unimed Medical Group, a Shenzhen-based third-party physicians group.
Lok leads $10m round for Indian diabetes clinic chain
Lok Capital has led a $10 million Series A round of funding for Indian diabetes care provider Dr. Mohan’s Diabetes Specialities Centre.
True North-led group to buy Religare Health Insurance for $162m
A consortium led by True North Managers will buy a majority stake in India’s Religare Health Insurance (RHI) for INR10.4 billion ($162 million).
Deal focus: True North keeps healthcare ball rolling
Having turned down Kerala Institute of Medical Sciences once due to potential conflicts of interest, True North moved quickly to deploy $200 million when presented with a second opportunity to invest in the hospital chain
Mahindra leads $21m round for India's Medwell
Mahindra Partners has led a $21 million Series B round for Indian home healthcare start-up Medwell Ventures, operator of Nightingales Home Health Services.
Sequoia India leads Series C for Australia's HealthEngine
Sequoia Capital India has made its debut investment in an Australia-based start-up, leading a A$26.7 million ($20.2 million) Series C round of funding for HealthEngine, an online healthcare marketplace.
Redpoint, Sinovation lead round for China online TCM player
Redpoint Ventures and Sinovation Ventures have led a Series B round worth RMB100 million ($14 million) for Xiaolu Clinic, a traditional Chinese medicine (TCM) online services provider.
True North invests $200m in India hospital chain
Indian private equity firm True North - formerly known as India Value Fund Advisors (IVFA) - has invested $200 million in domestic hospital chain Kerala Institute of Medical Sciences (KIMS).
HighLight seeks $250m for second China healthcare fund
Chinese healthcare-focused GP HighLight Capital, which was set up by Steven Wang, formerly of CDH Investments, is targeting $250 million for its second US dollar-denominated fund.
Korea to invest $102m in life science start-ups
The South Korean government has pledged to establish a KRW113.5 billion ($102 million) fund to support life science start-ups through related ecosystem and infrastructure investments.
Gateway invests in Singapore's Healthway Medical
Singapore-based private equity firm Gateway Partners has agreed to invest S$70 million ($50.2 million) in distressed local hospital operator Healthway Medical.
C-Bridge backs China pharma merger
China healthcare-focused GP C-Bridge Capital and Tasly Holding, a traditional Chinese medicine business, have agreed to invest $150 million in a newly-created entity formed through the merger of two local pharmaceutical companies.
Portfolio: Eight Roads and China's DeltaHealth
Eight Roads decided to leverage the development of China’s healthcare sector by building a hospital, but addressing the various challenges that come with a greenfield strategy requires very patient capital
SDIC Fund leads $40m Series B for Chinese drug developer
Suzhou Ribo Life Science, a Chinese drug developer that focuses on liver diseases, has raised a RMB270 million ($40 million) Series B round led by SDIC Fund Management.
TA buys stake in India's Ideal Cures
TA Associates has invested in Indian pharmaceutical product supplier Ideal Cures. Neither the size of the commitment nor the size of the GP's stake in the company were disclosed.
Japan's INCJ takes control of $87m pharma spin-out
The Innovation Network Corporation of Japan (INCJ) has teamed up with two pharmaceutical players to invest JPY10 billion ($87 million) in the creation of a biotech spin-out. INCJ will hold a 70.5% stake in the company.
Ally Bridge backs $301m Luoxin Pharma take-private
Healthcare-focused PE investor Ally Bridge Group will support the HK$2.3 billion ($301 million) management-led take-private of Hong Kong-listed Shandong Luoxin Pharmacy Group.
EDBI, Philips launch Singapore health tech investment platform
Singapore’s EDBI and Philips have formally launched an Asia-focused investment platform that targets companies in digital healthcare services.
Khazanah-backed fund part exits India's Apollo Hospitals for $160m
Integrated Healthcare Holdings (IHH), which is majority-owned by Malaysian sovereign wealth fund Khazanah Nasional, has sold part of its stake in India's Apollo Hospitals for INR10.7 billion ($160 million).
Hony's healthcare platform launches HK IPO
Hospital Corporation of China (HCC), a hospital operation group established by Hony Capital, has launched a Hong Kong IPO that would see the company raise as much as HK$500 million ($64 million).